Thermo Fisher Archives - Medical Design Sourcing

Key Tech names next CEO as co-founder plans to retire

Key Tech co-founder and CEO Jenny Regan [Photo courtesy of Key Tech]

Key Tech co-founder Jenny Regan plans to retire as CEO of the product development firm at the end of August, making way for VP of Strategy Alex Flamm to take her place.

Regan has been CEO since she and her co-founders launched the Baltimore firm in 1998. The company said it now has 75 interdisciplinary medical product designers and hundreds of clients in the medical technology industry, including Becton Dickinson, GE, Thermo Fisher, HemoSonics, GenMark and Abiomed.

Regan, who led Key Tech’s transition to a fully employee-owned company in 2019, will join the Key Tech Advisory Board.

“I’m incredibly proud of what we’ve built and how much good we’ve been able to do,” Regan said in an announcement posted to the company’s website last week. “I’m confident in our new leadership and will always be inspired by the talen…

Thermo Fisher opens plant to make COVID-19 testing supplies

(Image courtesy of Thermo Fisher)

Thermo Fisher Scientific (NYSE:TMO) announced today that it has opened its $40 million manufacturing facility in Lenexa, Kan.

The facility is dedicated to viral transport media (VTM) but will continue to expand to meet expected demand for COVID-19 testing, according to a news release.

In May, Thermo Fisher received a U.S. government contract to provide a significant quantity of highly specialized VTM for COVID-19 sample collection. The company said it ramped up production in Lenexa from 50,000 units per week to more than 8 million per week since the facility began production in early July.

Thermo Fisher said in the release that the new facility has created more than 300 new full-time jobs as it added 120,000 ft2 of manufacturing capacity.

Get the full story on our sister site, MassDevice.

DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?

DeviceTalks Weekly, powered by MassDevice

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week’s Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.

We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they’re making in developing a device to treat diabetes.

In a second interview, bioelectronic device company Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success in treating essential tremors and how the start-up is working through COVID-19.

Finally, Chris and Tom hint at an upcoming event for the DTW communit…